|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.08 USD | -2.94% |
|
-2.38% | -6.75% |
| Market Cap | 3.49B 3.07B 2.85B 2.62B 4.92B 338B 5.01B 34.1B 13.3B 165B 13.1B 12.82B 572B | P/E 2026 * |
207x | P/E 2027 * | 27.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.23B 2.84B 2.64B 2.42B 4.55B 312B 4.63B 31.51B 12.29B 152B 12.11B 11.85B 529B | EV / Sales 2026 * |
6.45x | EV / Sales 2027 * | 4.5x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | -3.28% | ||
| 1 week | -2.38% | ||
| Current month | +3.28% | ||
| 1 month | +3.08% | ||
| 3 months | +18.46% | ||
| 6 months | +3.36% | ||
| Current year | -6.75% |
| 1 week | 27.02 |  | 28.98 |
| 1 month | 25.25 | | 29.84 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.7 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 01/04/2017 |
| Corporate Officer/Principal | 71 | 03/12/2025 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 15/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 01/12/2019 |
Todd Watanabe
BRD | Director/Board Member | 58 | 01/01/2016 |
Howard Welgus
BRD | Director/Board Member | 74 | 01/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Other | Director | 187,500 | 0.1499% | ||
| 15/07/26 | Free | Director | 38,811 | 0.0310% | ||
| 15/07/26 | Fiscal year | Director | 12,922 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.94% | -2.38% | +81.62% | +162.91% | 3.49B | |
| -0.10% | -4.31% | +13.51% | -10.65% | 66.25B | |
| -0.12% | +3.10% | +40.83% | +196.27% | 52.86B | |
| +0.51% | +37.90% | +37.90% | +37.90% | 43.01B | |
| -1.86% | -4.93% | -56.15% | -56.66% | 39.52B | |
| +1.74% | -3.66% | +53.67% | -27.34% | 29.19B | |
| +0.30% | 0.00% | +65.02% | +83.82% | 23.13B | |
| -2.70% | -10.13% | +63.69% | -53.87% | 23.04B | |
| -1.30% | -6.18% | +3.94% | +177.59% | 20.48B | |
| -1.04% | -1.59% | +66.57% | +124.27% | 16.6B | |
| Average | -0.65% | -1.86% | +37.06% | +63.42% | 31.76B | |
| Weighted average by Cap. | -0.32% | -1.57% | +26.68% | +47.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 500M 440M 409M 376M 705M 48.43B 717M 4.89B 1.91B 23.62B 1.88B 1.84B 81.95B | 647M 569M 529M 486M 912M 62.68B 928M 6.32B 2.47B 30.57B 2.43B 2.38B 106B |
| Net income | 18.54M 16.31M 15.15M 13.93M 26.13M 1.8B 26.6M 181M 70.66M 876M 69.61M 68.11M 3.04B | 136M 119M 111M 102M 191M 13.14B 195M 1.33B 517M 6.41B 510M 498M 22.24B |
| Net Debt | -265M -233M -216M -199M -373M -25.62B -380M -2.58B -1.01B -12.5B -993M -972M -43.35B | -580M -510M -474M -436M -817M -56.15B -832M -5.67B -2.21B -27.39B -2.18B -2.13B -95.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | $27.08 | -2.94% | 530,748 |
| 22/07/26 | $27.90 | -1.27% | 802,453 |
| 21/07/26 | $28.26 | +2.65% | 1,370,446 |
| 20/07/26 | $27.53 | -3.37% | 1,254,200 |
| 17/07/26 | $28.49 | +2.70% | 1,265,376 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
